Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1993 Dec;77(12):766-70.
doi: 10.1136/bjo.77.12.766.

Clinical experience with interferon alfa-2a for exudative age-related macular degeneration

J N Kirkpatrick  1 , A D Dick, J V Forrester
Affiliations
Case Reports

Clinical experience with interferon alfa-2a for exudative age-related macular degeneration

J N Kirkpatrick et al. Br J Ophthalmol. 1993 Dec.

Abstract

There has been recent interest in the use of systemic interferon alfa-2a treatment for choroidal neovascular membranes (CNV). Here a pilot study is reported in which 10 patients with exudative age-related macular degeneration (ARMD) have been treated with a course of interferon injections. Of nine eyes with CNV there has been clinical and angiographic improvement in one eye and maintenance of visual acuity at pretreatment levels in three eyes (mean follow up period 7.6 months). Clinical appearance in five eyes was unchanged but these eyes still had active CNV. Two eyes with pigment epithelial detachment showed no clinical or angiographic change after interferon therapy although visual acuity in one eye had improved. Interferon alfa-2a may have a role to play in the treatment of ARMD as an adjunct to laser photocoagulation.

PubMed Disclaimer

Comment in

Comment on

References

    1. Am J Ophthalmol. 1992 Jan 15;113(1):45-51 - PubMed
    1. N Engl J Med. 1989 May 4;320(18):1197-200 - PubMed
    1. Am J Ophthalmol. 1973 Jul;76(1):1-18 - PubMed
    1. Arch Ophthalmol. 1991 Sep;109(9):1258-65 - PubMed
    1. Aust J Ophthalmol. 1980 May;8(2):117-30 - PubMed